CD38 and atherosclerosis: This study is designed to test the hypothesis that the CD38‐NAADP signalling pathway plays a critical role in removal of free cholesterol from lysosomes in macrophages and that the abnormalities in such CD38‐associated lysosome regulation may contribute to the lysosomal cholesterol accumulation and the pathogenesis of atherosclerosis.